Anesthesia and respiratory devices market seen climbing to $70.71B by 2030

Jul. 23, 2026
By AI, Created 18:15 UTC, Jul 23, 2026, AGP -

The Business Research Company says the anesthesia and respiratory devices market will rise from $42.45 billion in 2026 to $70.71 billion by 2030, driven by respiratory disease prevalence, healthcare spending and demand for smarter, portable care. Asia-Pacific led the market in 2025, while the report highlights growth in home-based respiratory care, connected monitoring and infection-control devices.

Why it matters: - The anesthesia and respiratory devices market is expanding because hospitals, clinics and home-care providers need more equipment to diagnose, monitor and treat respiratory disease. - The category is also tied to broader healthcare spending, surgical volume and infection-control priorities. - The report points to growing demand for connected monitoring, portable devices and intelligent anesthesia delivery systems.

What happened: - The Business Research Company published its 2026 market report on anesthesia and respiratory devices on July 24, 2026. - The market is projected to grow from $37.63 billion in 2025 to $42.45 billion in 2026. - The report forecasts the market will reach $70.71 billion by 2030. - The release includes a free sample of the report and the full market report.

The details: - The 2026-2030 outlook implies a 12.8% CAGR from 2025 to 2026 and a 13.6% CAGR through 2030. - Historical growth has been supported by rising respiratory disorders, stronger critical care infrastructure, more surgical procedures, wider access to respiratory diagnostics and higher use of disposable medical devices. - The report says future growth will be driven by home-based respiratory care, smart hospital investments, minimally invasive anesthesia delivery, remote patient monitoring and personalized respiratory treatment. - Key trends listed in the report include connected respiratory monitoring devices, portable and home-use respiratory equipment, intelligent anesthesia delivery systems, single-use respiratory disposables, and stronger patient safety and infection control. - The market covers tools used to administer medication and support care for conditions including asthma, cystic fibrosis and acute respiratory distress syndrome. - In 2025, Asia-Pacific was the largest regional market, followed by North America. - Eastern Europe had the smallest regional share. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - The forecast suggests the market is shifting from basic equipment demand toward more connected, portable and data-enabled systems. - Respiratory disease trends are providing the clearest near-term demand signal. - Government health spending data in the release reinforces that larger healthcare budgets can support adoption of higher-value devices. - In June 2025, the UK Office for Health Improvement & Disparities reported a 7% increase in emergency admissions for respiratory diseases in England from 2023 to 2024. - The same UK data showed COPD admissions rose 9%, adult asthma 17% and pneumonia 16%. - In June 2025, the US Centers for Medicare & Medicaid Services said national health expenditure reached $4.9 trillion in 2023, up 7.5%, and represented 17.6% of GDP. - CMS also reported hospital spending rose 10.4% to $1,519.7 billion in 2023.

What's next: - The Business Research Company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspot infographics, key technology analysis and updated visuals. - The company is steering attention toward adoption of smart hospital tools, remote monitoring and home-use respiratory equipment as the next growth phase. - The report suggests regional competition will continue to center on Asia-Pacific and North America as the largest markets.

The bottom line: - The market is moving into a faster-growth phase, with respiratory disease prevalence and technology upgrades doing most of the heavy lifting.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

The Europe Daily Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Europe Daily Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.